Biotech public [search 0]
×
Join millions of Player FM users today to get news and insights whenever you like, even when you're offline. Podcast smarter with the free podcast app that refuses to compromise. Let's play!
Join the world's best podcast app to manage your favorite shows online and play them offline on our Android and iOS apps. It's free and easy!
More
show episodes
 
Technology in Agriculture and Medicine for People and a Planet
 
Nature Biotechnology podcast is a series of conversations with founders, financers and developers from biotech's past, present and future.
 
A podcast dedicated to culturing knowledge in stem cell research.
 
T
The Bio Report
Weekly
 
The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.
 
T
The Disruptors
Weekly+
 
Long-form TED level conversations with top thinkers, founders and scientists on how advances in biotech & genomics, space travel, IoT, AI and other exponential tech converge to create our collective future and what we can do, from a research and policy perspective to shape the technology, trends and societal norms for a better world. If in-depth, unscripted conversations with the researchers, startups and future thinkers transforming our future in a Tim Ferriss meets Sam Harris, Kara Swisher ...
 
Welcome to The SynBioBeta Podcast: Conversations with synthetic biology’s leading thinkers on building a better world with biology. Hosted by John Cumbers, founder and CEO of SynBioBeta, where tech meets bio and bio meets tech. Stay updated on the latest news in synthetic biology, check out our weekly newsletter and follow us on social media: Twitter | LinkedIn | Facebook Be sure you make it to SynBioBeta 2019 this October 1-3! Click here for more information.
 
BioTech Nation Radio with Dr Moira Gunn
 
B
Breaking Biotech
Monthly+
 
Matt breaks down relevant biotech stocks, analyzing their data and determining if they are a good investment.
 
B
Breaking Biotech
Monthly+
 
Matt breaks down relevant biotech stocks, analyzing their data and determining if they are a good investment.
 
Discussion of genetic innovations to improve plants, animals and medicine
 
Nature Biotechnology podcast is a series of conversations with founders, financers and developers from biotech's past, present and future.
 
TechNation Radio hosted by Dr Moira Gunn
 
"The Long Run"Antarctic explorer Ernest Shackleton, if he were alive, would appreciate biotech. Today’s scientific entrepreneurs must be ready for the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina, and resilience, to achieve something meaningful. Biotech’s r ...
 
Bite-sized clips with TED level top thinkers, founders and scientists on how advances in biotech & genomics, space travel, IoT, AI and other exponential tech converge to create our collective future and what we can do, from a research and policy perspective to shape the trends, technologies and societal norms for a better world. Main Podcast: https://disruptors.fm/itunes If in-depth, unscripted conversations with the researchers, startups and future thinkers transforming the future of all of ...
 
Weekly interview show with people at the forefront of transformational technologies. Exploring emerging technologies, futurist ideas and the sociological, moral and philosophical impact of these exponential changes. MIND & MACHINE is focused on technologies and cultural forces that will transform our world: Artificial Intelligence, Robotics, Augmented Reality, Space Exploration, Life Extension, Blockchain, Cryptocurrencies, Virtual Reality, IoT Connected Devices, Genomics, Gene Editing, Tran ...
 
B
BloodStream
Μηνιαία
 
A monthly, 360-degree look at the bleeding disorders community, complete with news, interviews, and informed opinionating. Hosted by Patrick James Lynch. Produced by Believe Limited.
 
S
Sounds of Science
Monthly
 
Sounds of Science is a monthly podcast about beginnings: how a molecule becomes a drug, how a rodent elucidates a disease pathway, how a horseshoe crab morphs into an infection fighter. The podcast is produced by Eureka, the scientific blog of Charles River, a contract research organization for drug discovery and development. Tune in and begin the journey.
 
P
PharmaTalkRadio
Weekly+
 
PharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership ...
 
Johnson and Johnson Innovation is committed to advancing new healthcare solutions through collaboration. Our Podcast explores the latest trends in healthcare and the thinkers, organizations, and ideas behind them. Hosted by Caroline Baratz. Produced by Ryan Flinn.
 
Join our Keck Graduate Institute (KGI) community as we share behind-the-scenes insights on the innovation and collaboration taking place on campus. On this podcast, we share conversations with students, faculty, staff, alumni, and other guests. Visit our website at kgi.edu and follow us on social media @KeckGrad.
 
C
CHI Podcasts
Monthly+
 
The CHI Podcasts are produced by the Cambridge Healthtech Institute and offer in-depth interviews with research and business leaders from many facets of biotechnology.
 
D
Digital Biotech
Monthly
 
Interviews with innovators at the intersections of science, data, and technology.
 
T
The Syndicate
Weekly
 
Welcome to The Syndicate, the place where investors and startups combine to create crazy businesses and even crazier returns. The Syndicate podcast is a deep dive on the angel investors and VCs behind the big name startups. We interview the best and brightest investors, syndicate leads, GPs, limited partners and startup founders to create an original, off the cuff discussion on startup investing. With a focus on strategies and tactics, mistakes and massive money makers, we hope to help Angel ...
 
A weekly audio digest of the most important news in drug development affecting the pharmaceutical and biotech industry
 
A video podcast by the American Society for Microbiology that highlights the latest in microbiology, life science and biotechnology news. ASM is composed of over 42,000 scientists and health professionals with the mission to advance the microbial sciences as a vehicle for understanding life processes and to apply and communicate this knowledge for the improvement of health and environmental and economic well-being worldwide. For information about ASM and MicrobeWorld, visit us online at www. ...
 
The Promise of Biotech
 
Zahra covers the Indian Lifesciences landscape. Not just regular pharma, but also Biotech, Ayurveda and anything to do with LIFE!
 
A
Angel Invest Boston
Monthly+
 
Boston exports ideas and imports money. The city's unique concentration of academic talent and entrepreneurial culture is renowned for creating powerful new technologies and companies. These ideas and companies attract smart money from around the globe. This podcast surveys the companies that venture capitalists and strategic investors will be courting in a few years. I’m Sal Daher, host of the Angel Invest Boston Podcast. After immigrating to Boston as a child and attending Belmont High Sch ...
 
हाल ही में जोड़ा गया है, जल्द ही वापस देखें।
 
Welcome to Mintz’s, From the Edge, a podcast geared toward helping entrepreneurs thrive by learning from the experiences of executives in the technology, biotech and finance fields. On this podcast, Mintz partners who work with growing companies raising capital, building great management teams and achieving successful liquidity events will discuss with investors and entrepreneurs the key reasons that they were able to build successful companies and important lessons learned along the way. Mi ...
 
P
PharmaVOICE Podcasts
Daily+
 
PharmaVOICE interviews movers and shakers from the life sciences. We'll bring you interviews with executives from pharma and biotech as well as service providers to give you interesting stories from across the life sciences spectrum. It's all part of our mission to deliver a glimpse into the people who are forging the present and future of our industry.
 
V
Validating DeSantis
Daily+
 
A discussion for biotech and pharmaceutical engineering professionals
 
Genetic Engineering & Biotechnology News (GEN) has retained its position as the premier biotech publication since its launch in 1981. GEN publishes a print edition monthly and has additional exclusive editorial content online, including news and analysis as well as webinars, videos, and polls. GEN's unique news and technology focus covers the entire bioproduct life cycle, including drug discovery, early-stage R&D, applied research (e.g., omics, biomarkers, and diagnostics), bioprocessing, an ...
 
Anna Kavanaugh hosts the weekly radio series, "Mad Science: The Genetic Crossroad." The program aims to raise awareness and provide education about genetically modified organisms (GMO), in the world food supply and the practices of the GM biotech industry. The series is dedicated to all issues surrounding GM foods, its usage and ramifications thereof.Anna is a writer, advocate, and founder of the (AKCF) Anna Kavanaugh Charitable Foundation. Her original novel, "The Cord of Callows," now an u ...
 
I
Industry Focus
Daily
 
Healthcare, technology, energy, consumer goods, and more. Every day Motley Fool analysts break down a specific industry and the stocks making headlines. Questions? Comments? Email us at IndustryFocus@fool.com.
 
B
Biotalk
Monthly
 
Biotalk is a deal maker’s playbook to making an impact and generating returns in life sciences. Our guest speakers are industry leaders and institutional and family office investors who share their experience and views on deal making and industry trends to educate and inform.
 
Examining the impact of biotech discoveries on society and the law's role in shaping that impact.
 
Explore the world of cloning, protein folding, genome mapping, and more with the most important researchers in the field.Although the show is no longer in production at TWiT, you can enjoy episodes from the TWiT Archives.
 
Explore the world of cloning, protein folding, genome mapping, and more with the most important researchers in the field.Although the show is no longer in production at TWiT, you can enjoy episodes from the TWiT Archives.
 
Explore the world of cloning, protein folding, genome mapping, and more with the most important researchers in the field.Although the show is no longer in production at TWiT, you can enjoy episodes from the TWiT Archives.
 
T
The Readout Loud
Haftalık
 
Podcast by STAT
 
ThePostdocWay was created to provide an interactive space for social exchange between postdoctoral scholars. Our mission is to foster a sense of community by addressing issues related to the 'postdoc experience' and providing practical solutions. This objective is facilitated by engaging in original discussions focused on career development and exploration.
 
T
The Syndicate
Weekly
 
Welcome to The Syndicate, the place where investors and startups combine to create crazy businesses and even crazier returns. The Syndicate podcast is a deep dive on the angel investors and VCs behind the big name startups. We interview the best and brightest investors, syndicate leads, GPs, limited partners and startup founders to create an original, off the cuff discussion on startup investing. With a focus on strategies and tactics, mistakes and massive money makers, we hope to help Angel ...
 
T
The Pharmcast
Monthly
 
YourEncore's Pharmcast is your weekly dose of wisdom from today's top life science minds. Each week in the Pharmcast, we talk with top industry experts in our network or beyond about hot industry topics, leadership, and the path to success.
 
Get knowledge and inspiration to apply artificial intelligence to drug development. Discover startups applying machine learning to biomedical research. Hear how biotech and pharma companies use AI to speed discovery and cut costs. Learn from academic researchers pushing boundaries in applying computation to biology. We interview leaders transforming drug development with data and algorithms. Subscribe now and never miss an episode!
 
S
Signal
Monthly
 
The impact of modern medicine on the human condition can’t be underestimated. From antibiotics to vaccines, medicine has changed the way our bodies work, answered deadly questions, and promised faster cures. But it’s not simple. Drug development is rife with tension. It costs a lot of money, and takes a long time. Most things fail. But when they succeed, they can make a tremendous difference in people’s lives. Where will the next breakthroughs come from? How will we pay for them? Who decides ...
 
V
Venture Stories
Weekly+
 
Venture Stories by Village Global takes you inside the world of venture capital and technology, featuring enlightening interviews with entrepreneurs, investors and tech industry leaders. The podcast is hosted by Village Global partner and co-founder Erik Torenberg and produced by Brett Bolkowy. Check us out on the web at villageglobal.vc/podcast for more.
 
B
Biotalk
मासिक
 
Biotalk is a deal maker’s playbook to making an impact and generating returns in life sciences. Our guest speakers are industry leaders and institutional and family office investors who share their experience and views on deal making and industry trends to educate and inform.
 
Loading …
show series
 
Listen to the podcast interview with Dr. Danny Rittman, CTO of GBT Technologies Inc. (OTC PINK:GTCH) discussing the company's recently announced implementation and development of recurrent relational reasoning (RRN) in its AI, and its applications in the medical field.
 
The Farm Babe Michelle Miller is a farmer, speaker, columnist and blogger that advocates for agricultural producers, and seeks to better connect consumers to agricultural reality. She recently attended Farm Aid, the annual concert event [...]By Kevin M. Folta; Paul Vincelli.
 
STAT's Matthew Herper joins us to dig into the history of the infamous pain drug Vioxx and a new effort to bring it back as a rare disease treatment. Then, we discuss how the synthetic biology industry is growing up and getting corporate. Finally, health care journalist Maggie Fox dials in to explain her deep dive on venture capital in biotech.…
 
Here's why post-approval setbacks have caused Puma Biotechnology, Clovis Oncology, and Regenxbio shares to tumble, and if any of these stocks are finally worth buying. Stocks: PBYI, CLVS, RGNX Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's ...…
 
On this week’s Tech Nation, Moira speaks withit’s all about data – who’s collecting it, and why, and how it can serve us, and maybe not. Lee Omar from Red Ninja talks about smart cities around the world, and the art of listening before you build. Tech Nation Health Chief Correspondent Daniel Kraft shows us we can crowdsource medical questions, ...…
 
Today, I talk breast cancer and how Odonate's oral Taxane (Tesataxel) could garner the attention of doctor's looking to alleviate the burden of IV chemotherapy infusion in their patients. I discuss the latest macro news, biotech news, and compare previous Taxane revenue to see if my model is reasonable. www.breakingbiotech.com biotech #breaking ...…
 
Joining Erik on this episode are Laura Deming (@laurademing), creator of Longevity Fund, and Will Eden (@williamaeden), entrepreneur in residence with Errik Anderson at Ulysses and formerly of Thiel Capital. They talk about: - The history of biotech and the big trends and companies in the space over the past several decades. - The breakdown of ...…
 
The pipeline of adoptive T-cell therapies and other cell based immuno-oncology programs continues to expand with a number of modifications and improvements to the first generation programs. These platforms include improved spcificty and delivery - including non-viral platforms, targeting of multiple antigens, editing constructs, and a variety o ...…
 
Pfizer's latest phase 3 trial results put its promising eczema drug on a path to challenge Regeneron and Sanofi's $2 billion-per-year drug, Dupixent. Also, how Regenxbio and Adverum Biotechnologies hope to change how a we treat a common cause of vision loss in seniors, and why United Healthcare's latest quarterly results sent shares soaring. Ch ...…
 
This panel moderated by Dr Andrew Baum, Citi and recorded at the 5th annual IO360° Summit discusses the preparation of an IPO, straight licensing with the transition to a public company and decision making on prioritization within portfolios. Panelists include: David Epstein, Flagship PioneeringDan Passeri, Cue Biopharma Save the date for the 6 ...…
 
In this talk recorded at the 5th annual IO360° Summit, Dr Charles Link Jr, Newlink Genetics, addresses how IDO changes the T-cell balance in the tumor microenvironment. This talk addresses how: IDO creates local immunosuppression by increasing T regulatory cellsIDO often works in concert with PDL-1 mediated immunosuppressionIDO mediated T-cell ...…
 
Invest Alongside Boston's Top Angels: Our Syndicates - Get Qualified The need to re-skill is essential for workers confronting AI with obsolescent knowledge. Techstars alum Ace-Up is addressing this problem with a software platform that makes executive coaching more accessible and accountable. Founder Will Foussier opened for us a fascinating w ...…
 
Guest: Dr. Stephane Angers is a Professor and Associate Dean of Research in the Leslie Dan Faculty of Pharmacy at the University of Toronto. He is an expert in the field of signal transduction, working… The post Ep. 153: “Signal Transduction in Stem Cells and Cancer” Featuring Dr. Stephane Angers appeared first on Stem Cell Podcast.…
 
CEO of Synlogic on developing synthetic biology-based drugs.By Timmerman Report.
 
Chanticleer Holdings, the company that owns a handful of Hooters locations along with other eateries in the burger space is being purchased by Sonnet BioTherapeutics Inc., a company that makes cancer drugs. This isn’t a combination or a plan to get researchers to wear short shorts, it’s what’s called a reverse merger. Also, Costco has opened up ...…
 
August Bradley's guest today is Martin Bryant, a technology and media writer, speaker and consultant who puts out the Big Revolution newsletter on what's happening at the intersection of technology and media. Martin was previously the Editor In Chief of the TNW digital magazine which operates alongside the influential The Next Web conference on ...…
 
Eric Cole (@drericcole) is arguably the #1 cyber security expert in the US with a resume including the Obama administration, the CIA, the Gates Foundation and CTO of McAfee and was inducted into the 2014 InfoSecurity Hall of Fame. To listen to the entire episode, visit: https://disruptors.fm/99-why-hacking-and-cyberwarfare-is-big-business-for-r ...…
 
Erik is joined on this episode by Bret Weinstein (@BretWeinstein). He is a biologist and evolutionary theorist. They discuss: - His start in the field of evolutionary biology and how he realized that the big questions everyone thought had been answered actually only seemed that way because the big questions had stopped being asked. - Why two ch ...…
 
Meet Gina Mullane and Chris Garcia, the hosts of Vital Science, a brand new podcast that shares the personal stories of those impacted by life science. Today, Gina and Chris are responsible for global marketing and sales operations, but they both began their careers in the lab. They've experienced the impact of life science from every angle, an ...…
 
More CEOs are leaving their companies in 2019 than ever before. In today’s Industry Focus: Financials, our team breaks down why we’re seeing a record number of CEO departures and whether or not it’s good for a founder to keep running maturing businesses. Plus, Fool.com and Millionacres contributor Matt Frankel, CFP gives real estate investors a ...…
 
Frans von der Dunk is a Professor of Space Law at the University of Nebraska-Lincoln, Director of Black Holes Consultancy, and is generally recognized as one of the world’s leading space law experts. Franz has served as an adviser to a number of governments, the European Commission, ESA, the United Nations, the OECD, various national space... T ...…
 
Frans von der Dunk is a Professor of Space Law at the University of Nebraska-Lincoln, Director of Black Holes Consultancy, and is generally recognized as one of the world’s leading space law experts. Franz has served as an adviser to a number of governments, the European Commission, ESA, the United Nations, the OECD, various national space... T ...…
 
Anne Madden (@AnneAMadden) is a microbiologist, inventor, science communicator and CSO and founder of Lachancea, an innovative foodtech company focused on science of microorganisms.[spreaker type=player resource="episode_id=19498015" width="100%" height="80px" theme="light" playlist="false" playlist-continuous="false" autoplay="false" live-auto ...…
 
Anne Madden (@AnneAMadden) is a microbiologist, inventor, science communicator and CSO and founder of Lachancea, an innovative foodtech company focused on science of microorganisms.[spreaker type=player resource="episode_id=19498015" width="100%" height="80px" theme="light" playlist="false" playlist-continuous="false" autoplay="false" live-auto ...…
 
Bill Janeway (@billjaneway) joins Erik on this episode. Bill is a venture capitalist and economist and is the author of the classic book Doing Capitalism in the Innovation Economy. They talk about: - Bill’s keen interest in the interface of markets and government and how that thread has weaved its way through Bill’s career. - Why financializati ...…
 
The Farm Babe Michelle Miller is a farmer, speaker, columnist and blogger that advocates for agricultural producers, and seeks to better connect consumers to agricultural reality. She recently attended Farm Aid, the annual concert event [...]By Kevin M. Folta; Paul Vincelli.
 
Facebook CEO Mark Zuckerberg recently made comments about the company's ability to defend itself from anti-trust proceedings, so we revisit Senator Elizabeth Warren's outline for how and why companies like Amazon, Facebook, and Alphabet should be broken up. Plus, we hit some more anti-competitive issues facing Apple.Stocks: FB, AAPL, AMZN, GOOG ...…
 
On this week’s Tech Nation, Moira speaks withJournalist Maria Goodavage. Following her books “Soldier Dogs” and “Secret Service Dogs”, her latest is “Doctor Dogs, How Our Best Friends Are Becoming Our Best Medicine.”And ever wonder why those popular genetic tests don’t say you definitely will get a medical condition, but rather they cite a like ...…
 
Andrew Winston (@andrewwinston) is the founder of Winston Eco-Strategies, author of The Big Pivot and Green Recovery, and coauthored Green to Gold, the best-selling guide to what works — and what doesn't — when companies go green.[spreaker type=player resource="episode_id=19456572" width="100%" height="80px" theme="light" playlist="false" playl ...…
 
Andrew Winston (@andrewwinston) is the founder of Winston Eco-Strategies, author of The Big Pivot and Green Recovery, and coauthored Green to Gold, the best-selling guide to what works — and what doesn't — when companies go green.[spreaker type=player resource="episode_id=19456572" width="100%" height="80px" theme="light" playlist="false" playl ...…
 
With oil and gas production exploding in the U.S., takeaway capacity is running low, leading to oversupply and even flaring of unwanted natural gas that producers can’t get to market. That creates opportunities for midstream companies, businesses that build and operate the pipelines that take oil and gas to market. Motley Fool Contributor Matt ...…
 
Scientists can understand individual tumors at a molecular basis, but clinician don’t yet routinely profile and treat cancers based on this knowledge. Strata Oncology, with drug developers as its customer, is providing tumor profiling to cancer patients in the hopes of directing them into appropriate clinical trials. We spoke to Dan Rhodes, co- ...…
 
Sarah Perry (@sarahdoingthing), writer and thinker, joins Erik on this episode. They discuss: - Sarah’s writing career and what it means to “work through your politics” early in your career as a writer. - The purpose of rituals and why democracy is itself a form of ritual. - Why ambiguity increases meaning. - What we as a culture don’t understa ...…
 
In this episode of MintzEdge’s From the Edge podcast, Will Perkins speaks with Phil Gager of Stifel about venture debt. Will and Phil begin their discussion with an exploration of the background and basic terms of venture debt. They also dive deeply into the use cases — when a technology-driven emerging business should think about taking on ven ...…
 
These days it seems like all the struggling retailers are taking their strongest performing brands and spinning them out from the larger parent companies. J Crew plans to take its Madewell brand public, and Gap intends to spin out Old Navy. Why are so many companies choosing this path and what do investors need to know about these new concepts ...…
 
Google login Twitter login Classic login